Wells Fargo & Company Forecasts Strong Price Appreciation for Bath & Body Works (NYSE:BBWI) Stock

Bath & Body Works (NYSE:BBWI - Get Free Report) had its price target hoisted by stock analysts at Wells Fargo & Company from $38.00 to $42.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has an "equal weight" rating on the stock. Wells Fargo & Company's target price points to a potential upside of 12.24% from the company's current price.

A number of other equities research analysts have also weighed in on the stock. Bank of America decreased their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set a "buy" rating for the company in a report on Thursday, August 29th. Barclays boosted their price target on Bath & Body Works from $28.00 to $34.00 and gave the company an "underweight" rating in a report on Tuesday, November 26th. Evercore ISI reduced their price objective on Bath & Body Works from $45.00 to $35.00 and set an "in-line" rating on the stock in a report on Wednesday, August 28th. Morgan Stanley decreased their target price on Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating for the company in a research report on Thursday, November 21st. Finally, BMO Capital Markets reissued an "outperform" rating and set a $50.00 price target (down previously from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $42.50.

Bath & Body Works Trading Down 2.4 %

Shares of NYSE BBWI traded down $0.92 during trading hours on Thursday, hitting $37.42. 2,815,750 shares of the company traded hands, compared to its average volume of 4,020,733. The company's 50 day moving average price is $32.26 and its 200 day moving average price is $34.83. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99. The stock has a market capitalization of $8.10 billion, a price-to-earnings ratio of 9.31, a price-to-earnings-growth ratio of 1.37 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.58 billion. During the same quarter in the previous year, the business posted $0.48 earnings per share. The business's revenue was up 3.1% compared to the same quarter last year. Equities analysts anticipate that Bath & Body Works will post 3.26 EPS for the current year.

Insider Activity at Bath & Body Works

In related news, CEO Gina Boswell bought 6,000 shares of the company's stock in a transaction on Wednesday, October 9th. The shares were bought at an average price of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.27% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Bath & Body Works

Several institutional investors and hedge funds have recently made changes to their positions in BBWI. True Wealth Design LLC raised its stake in Bath & Body Works by 5,270.0% in the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock worth $34,000 after acquiring an additional 1,054 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its holdings in shares of Bath & Body Works by 300.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock valued at $38,000 after purchasing an additional 900 shares during the period. Wilmington Savings Fund Society FSB purchased a new position in shares of Bath & Body Works in the third quarter worth about $39,000. TD Private Client Wealth LLC raised its stake in shares of Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock worth $54,000 after purchasing an additional 331 shares during the last quarter. Finally, Meeder Asset Management Inc. lifted its holdings in shares of Bath & Body Works by 480.3% during the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company's stock worth $55,000 after purchasing an additional 1,436 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.